SurgLine International, Inc.
SGLN · OTC
7/31/2012 | 7/31/2011 | 7/31/2010 | 7/31/2009 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | 0.00 | 0.00 | 0.00 |
| FCF Yield | -13.37% | -11.81% | -11.85% | -28.69% |
| EV / EBITDA | -1.24 | -4.11 | -4.74 | -2.57 |
| Quality | ||||
| ROIC | 177.59% | 0.00% | 0.00% | 0.00% |
| Gross Margin | 34.42% | 0.00% | 0.00% | -770.50% |
| Cash Conversion Ratio | 0.13 | 0.52 | 0.14 | 0.17 |
| Growth | ||||
| Revenue 3-Year CAGR | – | -100.00% | -100.00% | – |
| Free Cash Flow Growth | -123.83% | -47.52% | 37.42% | 68.93% |
| Safety | ||||
| Net Debt / EBITDA | -0.15 | -0.37 | -2.06 | -1.28 |
| Interest Coverage | -7.53 | -1.74 | -1.91 | -1.49 |
| Efficiency | ||||
| Inventory Turnover | 5.66 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -2,884.98 | 0.00 | 0.00 | -487.45 |